BRCA1 and ovarian serous adenocarcinoma: Comprehensive and accurate analysis of BRCA1/2 genes is essential for individual and family genetic counseling in hereditary breast and ovarian cancers [32], as well as for establishing drug therapy with poly(ADP-ribose) (PARP) polymerases inhibitors in patients with high-grade serous ovarian cancer [33, 34].